501427-93-6 Usage
Uses
Used in Virology Research:
Neu5Ac alpha(2-6)Gal beta(1-4)GlcNAc-beta-pNP is used as a substrate for determining the recognition specificity of viruses for receptor sugar chains. This application is crucial in understanding how viruses bind to host cells and initiate infection, which can lead to the development of antiviral drugs and vaccines.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Neu5Ac alpha(2-6)Gal beta(1-4)GlcNAc-beta-pNP is used as a key component in the development of drugs targeting viral infections. By studying the interaction between this molecule and viral pathogens, researchers can design drugs that interfere with the virus's ability to bind to host cells, thereby preventing infection and spread.
Used in Diagnostics:
Neu5Ac alpha(2-6)Gal beta(1-4)GlcNAc-beta-pNP can also be employed in the development of diagnostic tools for detecting viral infections. By measuring the binding affinity of this molecule to specific viruses, diagnostic tests can be created to identify and monitor viral infections in patients.
Used in Glycobiology Research:
In the field of glycobiology, Neu5Ac alpha(2-6)Gal beta(1-4)GlcNAc-beta-pNP serves as an important model compound for studying the structure and function of glycans, which are essential for various biological processes, including cell-cell communication, immune response, and pathogen recognition. Understanding the role of this molecule in these processes can provide insights into the development of new therapeutic strategies for various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 501427-93-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,1,4,2 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 501427-93:
(8*5)+(7*0)+(6*1)+(5*4)+(4*2)+(3*7)+(2*9)+(1*3)=116
116 % 10 = 6
So 501427-93-6 is a valid CAS Registry Number.
InChI:InChI=1/C31H45N3O21/c1-11(37)32-19-15(39)7-31(30(46)47,55-27(19)21(41)16(40)8-35)50-10-18-22(42)24(44)25(45)29(53-18)54-26-17(9-36)52-28(20(23(26)43)33-12(2)38)51-14-5-3-13(4-6-14)34(48)49/h3-6,15-29,35-36,39-45H,7-10H2,1-2H3,(H,32,37)(H,33,38)(H,46,47)/t15-,16-,17+,18+,19-,20+,21-,22+,23-,24+,25+,26-,27-,28-,29+,31-/m1/s1
501427-93-6Relevant academic research and scientific papers
Zeng, Xiaoxiong,Uzawa, Hirotaka
, p. 2469 - 2475 (2005)
From the β-d-Gal-(1→4)-β-d-GlcNAc-OC6H 4NO2-p (1) prepared by the transglycosylation of β-galactosidase from Bacillus circulans, α-d-Neu5Ac-(2→3)- β-d-Gal-(1→4)-β-d-GlcNAc-OC6H4NO 2-p (9) a
